Home > Healthcare > Pharmaceuticals > Finished Drug Form > Spine Biologics Market
Spine Biologics Market Share
- Report ID: GMI6096
- Published Date: Jun 2023
- Report Format: PDF
Spine Biologics Market Share
The key players in the spine biologics market are
- Zimmer Biomet Holdings, Inc.
- Johnson and Johnson (Depuy Synthes)
- Orthofix Medical Inc.
- Stryker Corporation
- Arthrex, Inc.
- Medtronic, Inc.
- K2M, Inc.
- Exactech, Inc.
- Wright Medical Technology, Inc.
- Nuvasive, Inc.
Frequently Asked Questions (FAQ) :
Spine biologics industry share had reached USD 2.2 billion in 2022 and is estimated to witness 4.3% CAGR from 2023-2032 due to the rapidly expanding geriatric population and high burden of spine deformities worldwide
The bone graft substitutes product segment held 64.1% of the market share in 2022 driven by their ease of accessibility
The hospitals end-use segment is expected to record 4.1% CAGR from 2023-2032 owing to the robust presence of comprehensive healthcare facilities, including specialized departments and multidisciplinary teams
North America industry size may reach USD 1,409.2 million by 2032 due to the high prevalence of spinal conditions, such as degenerative disc disease, spinal stenosis, and spinal deformities in the region
Spine Biologics Market Scope
×
Get a free sample of
Spine Biologics Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below